namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
Published 7 days ago • 1.3K plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:59
namita thapar to gain ₹127.8 cr from emcure pharma ipo
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
1:00
emcure pharmaceuticals ipo review: is it worth your investment? | emcure pharma ipo | namita thapar
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
1:00
namita thapar's emcure pharmaceuticals ipo is finally hitting the markets. watch here to know more!
-
16:05
emcure pharma ipo summary | ca rachana ranade
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
4:06
emcure pharma ipo: all you need to know before investing
-
0:48
namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
-
25:46
namita thapar-backed emcure pharma’s rs 1,952 cr ipo opens|management on post-ipo roadmap| ipo watch
-
0:51
emcure pharma ipo good or bad to invest?
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
2:26
‘shark’ namita thapar’s investment swells 38,200% after strong emcure pharma listing! | details
-
1:00
emcure pharma ipo: invest करने से पहले जानें ये बातें! #iporeview
-
0:49
namita thapar's emcure pharma ipo - all details | latest gmp, date & price |#shorts #emcurepharmaipo
-
0:59
all you need to know about emcure pharma ipo | #namitathapar to make 293x returns!
-
0:43
namita thapar's emcure pharma makes bumper #stockmarket debut, lists at 31% premium on nse
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
8:41
emcure pharma ipo oversubscribed; growth & expansion plans | samit mehta & vikas thapar | et now
-
0:50
#sharktankindia fame namita thapar's emcure pharma lists at 31% premium on nse | new listing